Showing 1 - 20 results of 88,932 for search '(( 50 ((a decrease) OR (_ decrease)) ) OR ((( 50 mg decrease ) OR ( 1_ we decrease ))))*', query time: 1.30s Refine Results
  1. 1

    Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%. by Joseph Kamgno (81039)

    Published 2016
    “…<p>Pre-treatment LLM, month of start and end of sustained (≥ 4 months) decrease in LLM by ≥ 50% from pre-treatment LLM, to < 8100 mf/ml or < 30000 mf/ml by treatment arm for participants with a sustained decrease by ≥ 50%.…”
  2. 2
  3. 3
  4. 4
  5. 5

    Olaparib reverses the oxLDL-mediated decrease in co-immunoprecipitation of IκBα with RelA or p50. by Khamis Mustafa (17941332)

    Published 2024
    “…Relative band densities from three independent experiments were analyzed. (A) OxLDL decreased co-immunoprecipitation of IκBα with both RelA and p50, and olaparib reversed the effect of oxLDL on the dissociation of IκBα with RelA and p50. …”
  6. 6
  7. 7
  8. 8

    Hemodiafiltration Decreases Serum Levels of Inflammatory Mediators in Severe Leptospirosis: A Prospective Study by Sérgio Aparecido Cleto (3143949)

    Published 2016
    “…However, post-admission decreases in the serum levels of interleukin (IL)-17, IL-7, and monocyte chemoattractant protein-1 were significantly greater in the SLEDf group. …”
  9. 9

    Nasal mucociliary clearance was decreased in <i>Ttll1</i><sup>−/−</sup> mice. by Toshiyuki Iwata (419270)

    Published 2015
    “…<p>(A) Tosufloxacin (50 mg/kg) was administered to <i>Ttll1</i><sup>−/−</sup> mice with rhinosinusitis to inhibit cough for 7 days. …”
  10. 10
  11. 11

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    Subjects:
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis by Raj Vuppalanchi (458660)

    Published 2013
    “…In this study, we examined if certain microRNAs (miRNA) are associated with decreased hepatic CYP3A activity in cirrhosis.…”